MyFinsight
Home
Blog
About
Petros Pharmaceuticals, Inc. (PTPI)
Petros Pharmaceuticals, Inc. (PTPI)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$863,855
Unit: Dollar
Positive Cash Flow Breakdown
Employee stock-based compensatio...
Accrued expenses
Negative Cash Flow Breakdown
Operating loss from continuing o...
Accounts payable
Prepaid expenses and other curre...
Change in fair value of warrant ...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Operating loss from continuing operations
-955,625
-987,036
-336,506
2,809,766
Change in fair value of warrant liability
-900
-
-1,700
-1,000
Warrant issuance costs
-
-
0
0
Gain on asset disposition and vivus settlement
-
-
-
0
Gain from assignment of subsidiaries and vivus settlement
-
-
6,973,302
-
Employee stock-based compensation
117,906
120,319
75,138
229,496
Prepaid expenses and other current assets
15,124
15,124
-36,326
-12,140
Accounts payable
-36,022
49,421
-337,259
-548,883
Accrued expenses
25,910
48,148
-369,543
251,405
Net cash used in operating activities - continuing operations
-863,855
-784,272
-933,544
-1,133,924
Net cash (used in) provided by operating activities - discontinued operations
-
-
0
0
Net cash used in operating activities
-863,855
-784,272
-933,544
-1,133,924
Proceeds from common stock and prefunded warrants, net
-
-
0
0
Redemption of series a preferred stock
-
-
0
117,311
Net cash provided by (used in) financing activities - continuing operations
-
-
0
-117,311
Net cash provided by (used in) financing activities
-
-
0
-117,311
Net increase (decrease) in cash
-863,855
-784,272
-933,544
-1,251,235
Cash and cash equivalents, beginning of period
4,352,450
5,136,722
6,070,266
3,709,971
Cash and cash equivalents, end of period
3,488,595
4,352,450
5,136,722
6,070,266
Cash and cash equivalents, end of period - continuing operations
3,488,595
4,352,450
5,136,722
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net increase
(decrease) in cash
-$863,855
(-123.92%↓ Y/Y)
Net cash used in
operating activities
-$863,855
(81.49%↑ Y/Y)
Employee stock-based
compensation
$117,906
(-23.62%↓ Y/Y)
Accrued expenses
$25,910
(-83.91%↓ Y/Y)
Net cash used in
operating activities -...
-$863,855
(67.72%↑ Y/Y)
Canceled cashflow
$143,816
Operating loss from
continuing operations
-$955,625
Accounts payable
-$36,022
(-117.51%↓ Y/Y)
Prepaid expenses and
other current assets
$15,124
(-79.69%↓ Y/Y)
Change in fair value of
warrant liability
-$900
(99.99%↑ Y/Y)
Buy us a coffee